After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Emergent Biosolutions Inc is $529.92M. A total of 1.2 million shares were traded on the day, compared to an average of 1.24M shares.
In the most recent transaction, Glessner Coleen sold 30,608 shares of EBS for 10.00 per share on Oct 07 ’25. After the transaction, the EVP, Quality & Ethics, and CPL now owns 144,319 company shares. In a previous transaction on Oct 07 ’25, COLEEN GLESSNER bought 30,608 shares at 10.00 per share.
Among the insiders who sold shares, Zoon Kathryn C disposed of 7,086 shares on Aug 15 ’25 at a per-share price of $8.87. This resulted in the Director holding 71,799 shares of EBS after the transaction. In another insider transaction, KATHRYN ZOON bought 7,086 shares at $8.87 per share on Aug 15 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, EBS has a high of $13.41 and a low of $4.02.
As of this writing, EBS has an earnings estimate of $0.42 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.64 per share and a lower estimate of $0.21. The company reported an EPS of $0.05 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EBS’s latest balance sheet shows that the firm has $576.10M in Cash & Short Term Investments as of fiscal 2021. There were $841.00M in debt and $374.00M in liabilities at the time. Its Book Value Per Share was $11.05, while its Total Shareholder’s Equity was $1.61B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EBS is Buy with a score of 3.50.
